Analysts Have Conflicting Sentiments on These Healthcare Companies: Rain Therapeutics (RAIN), Arcadia Biosciences (RKDA) and Eiger Biopharmaceuticals (EIGR)
Analysts Are Bullish on These Healthcare Stocks: Ocular Therapeutix (OCUL), Eiger Biopharmaceuticals (EIGR)
Eiger Biopharmaceuticals (EIGR) Gets a Buy From Ladenburg Thalmann & Co.
Citi Sticks to Their Buy Rating for Eiger Biopharmaceuticals (EIGR)
Citigroup Maintains Buy on Eiger BioPharmaceuticals, Lowers Price Target to $3
Eiger BioPharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Eiger Biopharmaceuticals (EIGR) and Atossa Therapeutics (ATOS)
Baird Adjusts Price Target on Eiger BioPharmaceuticals to $5 From $3, Maintains Outperform Rating
Baird Maintains Outperform on Eiger BioPharmaceuticals, Raises Price Target to $5
Eiger Biopharmaceuticals (EIGR) Gets a Buy From Ladenburg Thalmann & Co.
Robert W. Baird Sticks to Its Buy Rating for Eiger Biopharmaceuticals (EIGR)
Eiger Biopharmaceuticals (EIGR) Receives a Buy From Ladenburg Thalmann & Co.
Eiger Biopharmaceuticals (EIGR) Receives a Buy From BTIG
BTIG Sticks to Its Buy Rating for Eiger Biopharmaceuticals (EIGR)
Ladenburg Thalmann & Co. Reaffirms Their Buy Rating on Eiger Biopharmaceuticals (EIGR)
Robert W. Baird Sticks to Its Buy Rating for Eiger Biopharmaceuticals (EIGR)
Analysts Offer Insights on Healthcare Companies: Eiger Biopharmaceuticals (EIGR) and Magenta Therapeutics (MGTA)
Ladenburg Thalmann & Co. Keeps Their Buy Rating on Eiger Biopharmaceuticals (EIGR)
Analysts Offer Insights on Healthcare Companies: Eiger Biopharmaceuticals (EIGR), Sanofi (OtherSNYNF) and Processa Pharmaceuticals (PCSA)